![]() ![]() The whistleblower will receive 17 percent of the money recovered, about $2.7 million, and Inform also agreed to pay the whistleblower another $62,000 for attorney's fees and other costs. The allegations contained in the DOJ settlement result from a whistleblower lawsuit brought against Inform Diagnostics in 2019 pursuant to provisions of the federal False Claims Act. In a complaint filed with the US District Court for the District of Massachusetts prosecutors also alleged Inform Diagnostics had instructed its histotechnicians to determine which tests to perform and submit for billing prior to any analysis by a pathologist. Inform Diagnostics is a leading national pathology laboratory, headquartered in Irving, Texas, with additional state-of-the-art laboratories in Boston. Inform Diagnostics - A Fulgent Genetics Company, Irving, Texas. Ongoing Medication: Kindly inform us about any ongoing medications for you. Genomic testing firm Fulgent Genetics is acquiring Inform Diagnostics, an independent national pathology laboratory, for approximately 170 million. In the agreement with the DOJ, Inform officials admitted to routinely conducting periodic acid-Schiff-Alcian Blue and immunohistochemical stains on gastrointestinal biopsy specimens and periodic acid-Schiff stains on dermatological biopsy specimens. PET CT is a diagnostic imaging test primarily used for detection of cancer. Molecular Immunoassay- 0 30 60 90 120 150 180 D 11 Lab - based near PoC or POC CE. The DOJ said those tests were unnecessary and billing federal health programs for them constituted fraud.įulgent Genetics acquired Inform, based in Irving Texas, in April for $170 million.Īccording to the settlement agreement document, Inform conducted the additional tests without consulting the treating physicians or any pathologists' findings. This can be used to inform diagnostics and vaccine development. The two organizations first crossed paths in late 2018 when Inform Diagnostics was looking to transform its major systems, including ERP, CRM, HR and lab information, and support these initiatives with cloud-based infrastructure. The US Attorney's Office District of Massachusetts said that Inform, formerly called Miraca Life Sciences, admitted that from 2013 to 2018, it routinely and automatically conducted additional tests on biopsy specimens before a pathologist's review and without a determination those tests were needed. NEW YORK - Pathology laboratory Inform Diagnostics has agreed to pay the federal government $16 million for conducting unnecessary tests on biopsy specimens, the US Department of Justice said on Wednesday.Īccording to the department, the tests conducted by Inform resulted in false payment claims to Medicare and other federal health care programs. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |